ナロキソンスプレーの世界市場レポート 2024年

ナロキソンスプレーの市場規模は近年急激に拡大しています。2023年の5,406億8,000万米ドルから2024年には6,686億米ドルへと、CAGR 23.7％で拡大します。この期間の成長は、オピオイド過剰摂取の増加、先進国を中心としたオピオイド薬物乱用の増加、医薬品開発の進歩、ナロキソンスプレーの重要性に関する意識の高まり、医療支出の一般的な増加など、いくつかの要因によるものです。

2023年のナロキソンスプレー市場で最大の地域は北米でした。ナロキソンスプレー市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 ナロキソンスプレー市場の特徴

第3章 ナロキソンスプレー市場の動向と戦略

第4章 ナロキソンスプレー市場- マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界のナロキソンスプレー市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033F

第6章 ナロキソンスプレー市場セグメンテーション

• 世界のナロキソンスプレー市場、用量別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 2mg
• 4mg
• 世界のナロキソンスプレー市場、流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 病院
• クリニック
• 小売薬局
• オンライン薬局
• その他

第7章 ナロキソンスプレー市場の地域別・国別分析

• 世界のナロキソンスプレー市場、地域別、実績および予測、2018-2023、2023-2028F、2033F
• 世界のナロキソンスプレー市場、国別、実績および予測、2018-2023、2023-2028F、2033F

第8章 アジア太平洋のナロキソンスプレー市場

• 概要
• 地域情報、COVID-19症の影響、市場情報、背景情報、政府の取り組み、規制、規制機関、主要団体、課税額、法人税構造、投資、主要企業
• 用量別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第9章 中国のナロキソンスプレー市場

第10章 インドのナロキソンスプレー市場

第11章 日本のナロキソンスプレー市場

第12章 オーストラリアのナロキソンスプレー市場

第13章 インドネシアのナロキソンスプレー市場

第14章 韓国のナロキソンスプレー市場

第15章 西欧のナロキソンスプレー市場

• 概要
• 用量別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第16章 英国のナロキソンスプレー市場

第17章 ドイツのナロキソンスプレー市場

第18章 フランスのナロキソンスプレー市場

第19章 イタリアのナロキソンスプレー市場

第20章 スペインのナロキソンスプレー市場

第21章 東欧のナロキソンスプレー市場

• 概要
• 用量別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第22章 ロシアのナロキソンスプレー市場

第23章 北米のナロキソンスプレー市場

• 概要
• 用量別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第24章 米国のナロキソンスプレー市場

第25章 カナダのナロキソンスプレー市場

第26章 南米のナロキソンスプレー市場

• 概要
• 用量別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第27章 ブラジルのナロキソンスプレー市場

第28章 中東のナロキソンスプレー市場

• 概要
• 用量別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第29章 アフリカのナロキソンスプレー市場

• 概要
• 用量別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F
• 流通チャネル別セグメンテーション、実績および予測、2018-2023、2023-2028F、2033F

第30章 ナロキソンスプレー市場の競合情勢と企業プロファイル

• ナロキソンスプレー市場の競合情勢
• ナロキソンスプレー市場の企業プロファイル
  • Emergent BioSolutions Inc.
  • Amphastar Pharmaceuticals Inc.
  • Hikma Pharmaceuticals plc
  • Indivior plc
  • Nasus Pharma LLC

第31章 世界のナロキソンスプレー市場の競合ベンチマーキング

第32章 世界のナロキソンスプレー市場の競合ダッシュボード

第33章 ナロキソンスプレー市場における主要な合併と買収

第34章 ナロキソンスプレー市場の将来展望と可能性分析

第35章 付録

“Naloxone Spray Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on naloxone spray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for naloxone spray? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The naloxone spray market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Dosage: 2 mg/Actuation; 4 mg/Actuation
• 2) By Distribution Channel: Hospitals; Clinics; Retail Pharmacies; Online Pharmacies; Other distribution channels
• Companies Mentioned: Emergent BioSolutions Inc.; Amphastar Pharmaceuticals Inc.; Hikma Pharmaceuticals plc; Indivior plc; Nasus Pharma LLC
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Naloxone spray is a substance that binds to opioid receptors, effectively inhibiting or reversing the actions of other opioids. Administering naloxone promptly can counteract the effects of opioid medications and restore normal breathing. This can be achieved through intravenous injection or nasal spray. Naloxone is typically dispensed as a solution in liquid form, designed for spraying into the nose, with each nasal spray containing a single dose intended for one-time use.

The main dosage options for naloxone spray are 2 mg/actuation and 4 mg/actuation. The 2 mg/actuation naloxone spray, equivalent to 1. 8 mg of naloxone, is utilized as an emergency medication for known or suspected opioid overdose, as indicated by respiratory and/or central nervous system depression. The 2 mg dose is licensed for use in opioid-dependent individuals at risk of severe opioid withdrawal, residing in an environment with low risk of accidental or intentional opioid exposure from household contacts. Naloxone sprays are available through various distribution channels, including hospitals, clinics, retail pharmacies, online pharmacies, and others.

The naloxone spray market research report is one of a series of new reports from The Business Research Company that provides naloxone spray market statistics, including naloxone spray industry global market size, regional shares, competitors with a naloxone spray market share, detailed naloxone spray market segments, market trends and opportunities, and any further data you may need to thrive in the naloxone spray industry. This naloxone spray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The naloxone spray market size has grown exponentially in recent years. It will grow from $540. 68 billion in 2023 to $668. 6 billion in 2024 at a compound annual growth rate (CAGR) of 23. 7%. The growth observed in the historical period can be attributed to several factors, including the increased prevalence of opioid overdose, a rise in cases of opioid drug abuse particularly in developed countries, advancements in drug development, an increasing awareness regarding the importance of naloxone spray, and a general growth in healthcare expenditure.

The naloxone spray market size is expected to see exponential growth in the next few years. It will grow to $1592. 93 billion in 2028 at a compound annual growth rate (CAGR) of 24. 2%. The anticipated growth in the forecast period can be attributed to supportive government initiatives promoting naloxone distribution, the expansion of accessibility programs for naloxone, an increase in prescription rates for opioid analgesics, and ongoing efforts to address and combat the opioid crisis. Major trends expected in the forecast period include the adoption of intranasal naloxone formulations, the development of user-friendly naloxone devices, the integration of naloxone education in opioid prescribing practices, and the inclusion of naloxone in community-based harm reduction programs.

The growth of the naloxone spray market is attributed to the increasing prevalence of opioid overdoses. Opioids, including morphine, fentanyl, and tramadol, are utilized for pain treatment, but their non-medical use, prolonged usage, misuse, or unsupervised use can lead to opioid dependence and severe health complications, including fatalities. According to a Centers for Disease Control and Prevention (CDC) report in February 2021, opioids were involved in 70. 6% of all drug overdose deaths, totaling 49,860 cases. Naloxone nasal spray plays a crucial role in emergency medical treatment by reversing the life-threatening effects of opioid overdoses, thereby driving the growth of the naloxone spray market.

The anticipated growth of the naloxone spray market is also linked to the increasing demand for telemedicine. Telemedicine, or telehealth, utilizes technology to provide remote medical services, offering comprehensive and immediate support to individuals at risk of opioid overdose. This approach proves valuable in addressing the opioid crisis effectively. In April 2023, National telehealth use increased by 7. 3%, reaching 5. 9% of medical claim lines, according to FAIR Health Inc. The rising demand for telemedicine contributes to the expansion of the naloxone spray market.

Product approvals are playing a pivotal role in shaping the naloxone spray market. Key manufacturers of naloxone sprays are focused on obtaining approvals for new products to diversify their portfolios and enhance their presence in the naloxone spray business. For example, in April 2021, the US Food and Drug Administration (FDA) approved Hikma Pharmaceuticals' KLOXXADOTM nasal spray for the immediate treatment of opioid overdose. This approval represents a significant step in addressing the opioid epidemic and provides an effective solution to reverse the effects of opioid overdose.

Major companies in the naloxone spray market are directing their efforts towards innovative products like Narcan to boost market revenues. Narcan nasal spray, launched by Sandoz International GmbH in December 2021, is designed to rapidly reverse the effects of opioid overdoses, including those caused by heroin, fentanyl, morphine, or prescription opioid painkillers. It acts swiftly to block the impact of opioids on the brain, restoring normal breathing and consciousness in individuals experiencing an overdose.

In March 2021, Aptar Pharma, a US-based pharmaceutical company, announced a collaboration with DNE Pharma, a Norwegian pharmaceutical company, to develop addiction medicines. This partnership, utilizing Ford Pharma's Ventizolve nasal naloxone, focuses on enhancing patient access and addressing the opioid epidemic through training programs and expertise in nasal drug delivery treatment for opioid overdoses.

Major companies operating in the in the naloxone spray market report are Emergent BioSolutions Inc., Amphastar Pharmaceuticals Inc., Hikma Pharmaceuticals plc, Indivior plc, Nasus Pharma LLC, Neon Laboratories Limited, Opiant Pharmaceuticals Inc., Pfizer Inc., Samarth Pharma Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Troikaa Pharmaceuticals Ltd., Adapt Pharma Inc., AmerisourceBergen Corporation, Cardinal Health Inc., CVS Health Corporation, Express Scripts Holding Company, Harm Reduction Coalition Inc., Kaleo Inc., McKesson Corporation, Mundipharma International Limited, Mylan N. V., NextDistro Inc., Rite Aid Corporation, Novartis International AG, Sandoz International GmbH, Fresenius Kabi USA LLC, Hospira Inc., West-Ward Pharmaceuticals Corp., Walgreens Boots Alliance Inc., Lupin Ltd.

North America was the largest region in the naloxone spray market in 2023. The regions covered in the naloxone spray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the naloxone spray market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The naloxone spray market consists of sales of injectable and prepackaged nasal spray. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified)).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Naloxone Spray Market Characteristics

3. Naloxone Spray Market Trends And Strategies

4. Naloxone Spray Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Naloxone Spray Market Size and Growth

• 5.1. Global Naloxone Spray Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Naloxone Spray Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Naloxone Spray Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Naloxone Spray Market Segmentation

• 6.1. Global Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

2 mg/Actuation

4 mg/Actuation

• 6.2. Global Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Clinics
• Retail Pharmacies
• Online Pharmacies
• Other distribution channels

7. Naloxone Spray Market Regional And Country Analysis

• 7.1. Global Naloxone Spray Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Naloxone Spray Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Naloxone Spray Market

• 8.1. Asia-Pacific Naloxone Spray Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Naloxone Spray Market

• 9.1. China Naloxone Spray Market Overview
• 9.2. China Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Naloxone Spray Market

• 10.1. India Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Naloxone Spray Market

• 11.1. Japan Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.2. Japan Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Naloxone Spray Market

• 12.1. Australia Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Naloxone Spray Market

• 13.1. Indonesia Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Naloxone Spray Market

• 14.1. South Korea Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.2. South Korea Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Naloxone Spray Market

• 15.1. Western Europe Naloxone Spray Market Overview
• 15.2. Western Europe Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Naloxone Spray Market

• 16.1. UK Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Naloxone Spray Market

• 17.1. Germany Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Naloxone Spray Market

• 18. 1. France Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18. 2. France Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Naloxone Spray Market

• 19. 1. Italy Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19. 2. Italy Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Naloxone Spray Market

• 20.1. Spain Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Naloxone Spray Market

• 21.1. Eastern Europe Naloxone Spray Market Overview
• 21.2. Eastern Europe Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Naloxone Spray Market

• 22.1. Russia Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Naloxone Spray Market

• 23.1. North America Naloxone Spray Market Overview
• 23.2. North America Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Naloxone Spray Market

• 24.1. USA Naloxone Spray Market Overview
• 24.2. USA Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Naloxone Spray Market

• 25.1. Canada Naloxone Spray Market Overview
• 25.2. Canada Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Naloxone Spray Market

• 26.1. South America Naloxone Spray Market Overview
• 26.2. South America Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Naloxone Spray Market

• 27.1. Brazil Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Naloxone Spray Market

• 28.1. Middle East Naloxone Spray Market Overview
• 28.2. Middle East Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Naloxone Spray Market

• 29.1. Africa Naloxone Spray Market Overview
• 29.2. Africa Naloxone Spray Market, Segmentation By Dosage, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Naloxone Spray Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Naloxone Spray Market Competitive Landscape And Company Profiles

• 30.1. Naloxone Spray Market Competitive Landscape
• 30.2. Naloxone Spray Market Company Profiles
  • 30.2.1. Emergent BioSolutions Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1. 4. Financial Performance
  • 30.2.2. Amphastar Pharmaceuticals Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2. 4. Financial Performance
  • 30.2.3. Hikma Pharmaceuticals plc
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3. 4. Financial Performance
  • 30.2. 4. Indivior plc
    • 30.2. 4.1. Overview
    • 30.2. 4.2. Products and Services
    • 30.2. 4.3. Strategy
    • 30.2. 4. 4. Financial Performance
  • 30.2. 5. Nasus Pharma LLC
    • 30.2. 5.1. Overview
    • 30.2. 5.2. Products and Services
    • 30.2. 5.3. Strategy
    • 30.2. 5. 4. Financial Performance

31. Global Naloxone Spray Market Competitive Benchmarking

32. Global Naloxone Spray Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Naloxone Spray Market

34. Naloxone Spray Market Future Outlook and Potential Analysis

• 34.1 Naloxone Spray Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Naloxone Spray Market In 2028 - Segments Offering Most New Opportunities
• 34. 3 Naloxone Spray Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35. 4. Research Inquiries
• 35. 5. The Business Research Company
• 35. 6. Copyright And Disclaimer